CTKB Q3 2023 Earnings — Cytek Biosciences, Inc. Revenue & Financial Results | Market Cap Arena

CTKBCytek Biosciences, Inc.

$553M

Q3 2023 Earnings

Healthcare Medical - Devices

Income Statement

Revenue

$48M+18.6% YoY

Gross Profit

$27M56.6% margin

Operating Income

-$6M-13.4% margin

Net Income

-$6M-13.5% margin

EPS (Diluted)

$-0.05

QoQ Revenue Growth

-3.4%

Cash Flow

Operating Cash Flow

-$4M

Free Cash Flow

-$6M

Stock-Based Comp.

$6M

Balance Sheet

Total Assets

$519M

Total Liabilities

$104M

Stockholders' Equity

$416M

Cash & Equivalents

$164M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$48M	$40M	+18.6%
Gross Profit	$27M	$27M	+1.2%
Operating Income	-$6M	$1M	-572.1%
Net Income	-$6M	$2M	-487.5%

Revenue Segments

Product

$38M51%

Service

$37M49%

Geographic Segments

UNITED STATES

$27M56%

EMEA

$13M27%

Asia Pacific

$7M14%

Other

$2M3%